New pill for postpartum depression a vital breakthrough

New pill for postpartum depression a vital breakthrough
One in seven new mothers develop the serious medical condition. (Image: Getty)
Bloomberg
By Lisa Jarvis The landmark approval in the US of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who develop the condition. Suicide is a leading cause of maternal mortality in the US. And yet on its own, the new drug – promising as it is – isn’t enough. Consider that as many as half of women with postpartum depression go undiagnosed.Nonetheless, the new pill is a remarkable breakthrough, and one of several encouraging recent developments in women’s health &...

More Health

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Editor's Picks

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

Evithé Biotechnology's founder is a 2024 KiwiNet award finalist.

Greg Hurrell 30 Aug 2024
Dunedin Hospital under 'active consideration'
Infrastructure

Dunedin Hospital under 'active consideration'

Lester Levy wants to review all health projects and programmes.

Oliver Lewis 09 Aug 2024
Running NZ to failure
Economy

Dileepa Fonseka: Running NZ to failure

Where 'legacy' means old and broken.

Dileepa Fonseka 29 Jul 2024
Minister's $200m tobacco tax cut bypasses Cabinet requirements
Policy

Minister's $200m tobacco tax cut bypasses Cabinet requirements

Researchers say there's more evidence to support the repealed Smokefree policies.

Jem Traylen 26 Jul 2024